Evaluation of Diabetes Self-Management Consultant Care

Not Applicable

Completed

• Conditions: Type 2 Diabetes Mellitus
• Interventions: Behavioral: Diabetes Self-Management Consultant; Behavioral: Enhanced Usual Care Control Group

• Registration Number: NCT00109720
• Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Brief Summary

The purpose of this study is to find out if Self-Management Consultant (SMC) intervention will be more effective than usual care in improving blood glucose control and diabetes-related quality of life for adults with type 2 diabetes.

Detailed Description

This study is designed to compare the effectiveness of a diabetes Self-Management Consultant (SMC) intervention for adults with type 2 diabetes with unsatisfactory glucose control (i.e., HbA1c ≥ 8%--the value chosen as "high risk" by the Diabetes Quality Improvement Project which is an initiative of the Health Care Financing Administration, the American Diabetes Association, and the Foundation for Accountability) to a control group selected using the same criteria. The SMC intervention will be implemented and evaluated in two different health care systems serving two distinct populations of patients with diabetes. After signing the Informed Consent document, subjects will be randomized to the SMC intervention or a control group. All subjects in the study will complete a baseline assessment of their diabetes care and health status.

Subjects randomized to the SMC intervention will have an individual meeting with the SMC to review and refine a self-management plan based on the subject's priorities and goals. These subjects will receive individual follow-up and support during the year, through monthly phone calls and an annual meeting with the SMC and their primary care physician. Subjects randomized to the control group will receive usual care following their baseline and their 12-, 24-, and 36-month assessments. Unlike most nurse-manager studies, the SMC's interactions with patient care will use a theory-based behavioral approach with which we have extensive experience. The study is designed to evaluate the effectiveness of the SMC intervention compared to usual care.

All records will be handled confidentially. Lab results and personal data will be linked by a research specific identifier code.

Study Timeline

• Study Start: 2002-08
• Study First Submitted: 2005-05-02
• Study First Submitted QC: 2005-05-02
• Study First Posted: 2005-05-03
• Study Completion: 2007-07
• Status Verified: 2010-01
• Last Update Submitted: 2010-01-14
• Last Update Posted: 2010-01-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 310

Inclusion Criteria

• Adults over age 21 diagnosed with type 2 diabetes for at least one year.

Exclusion Criteria

• Patients under psychiatric care
• Currently pregnant
• Those who have not been diagnosed with type 2 diabetes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Diabetes Self-Management Consultant	Patients in the experimental group received the services of a Diabetes Self-Management Consultant (DSC)
2	Enhanced Usual Care Control Group	This Arm was a Enhanced Usual Care Control group who continued with their usual care but also they and their physicians received the results of all metabolic assessments obtained during the study.

Primary Outcome Measures

Name	Time	Method
Blood glucose level	two years

Secondary Outcome Measures

Name	Time	Method
Diabetes Related Quality of life	two years

Trial Locations

Locations (2)

University of Michigan, Department of Family Medicine Clinics; 🇺🇸 Ann Arbor, Michigan, United States

Detroit Health Department; 🇺🇸 Detroit, Michigan, United States